Risk factor
Fair trading liquidity
Profitability factor
Good growth
About
Nanjing Well Pharmaceutical Group Co., Ltd., founded in 2000 and headquartered in Nanjing, China, is primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical excipients within the Chinese market. These essential auxiliary materials are utilized in both injectable and non-injectable drug formulations. Beyond its pharmaceutical focus, the company also supplies an extensive range of synthetic base oils for various industrial applications, including hydraulic fluids, lubricity additives for metals, metal quenching agents, compression lubricants, gear oils, chain lubricants, and base stocks for engine oils, heat transfer oils, and greases. Furthermore, its product portfolio diversifies into other specialized chemicals such as paints and coatings, textile chemicals, field chemicals, and low-foam metal cleaners. The company boasts a global presence, exporting its products to key markets in Europe, the United States, Southeast Asia, and other international regions. Originally known as Nanjing Well Pharmaceutical Co., Ltd., the company officially adopted its current name, Nanjing Well Pharmaceutical Group Co., Ltd., in April 2020.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV